|
PHF16 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.09419999999128E-05 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.120800E-03 |
| Normal-vs-Stage2 |
1.975750E-03 |
| Normal-vs-Stage3 |
1.65924999999678E-05 |
| Normal-vs-Stage4 |
9.87070000000312E-05 |
| Stage1-vs-Stage2 |
1.898800E-01 |
| Stage1-vs-Stage3 |
1.268030E-02 |
| Stage1-vs-Stage4 |
3.708300E-02 |
| Stage2-vs-Stage3 |
5.051800E-01 |
| Stage2-vs-Stage4 |
5.684400E-01 |
| Stage3-vs-Stage4 |
9.368800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.96569999999707E-05 |
| Normal-vs-AfricanAmerican |
4.193900E-04 |
| Normal-vs-Asian |
2.329000E-01 |
| Caucasian-vs-AfricanAmerican |
4.309600E-01 |
| Caucasian-vs-Asian |
8.155000E-01 |
| AfricanAmerican-vs-Asian |
5.998400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.3106000000015E-05 |
| Normal-vs-Female |
9.84229999999586E-05 |
| Male-vs-Female |
9.367800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.541000E-03 |
| Normal-vs-Age(41-60Yrs) |
2.296500E-03 |
| Normal-vs-Age(61-80Yrs) |
1.5159999999792E-06 |
| Normal-vs-Age(81-100Yrs) |
4.763100E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.146600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.209400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.508000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.567500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.064600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.615600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.776400E-01 |
| Normal-vs-Grade 2 |
3.963300E-03 |
| Normal-vs-Grade 3 |
4.60820000003359E-06 |
| Normal-vs-Grade 4 |
1.57645999999678E-05 |
| Grade 1-vs-Grade 2 |
1.704050E-01 |
| Grade 1-vs-Grade 3 |
5.138200E-02 |
| Grade 1-vs-Grade 4 |
2.510000E-02 |
| Grade 2-vs-Grade 3 |
2.691900E-02 |
| Grade 2-vs-Grade 4 |
7.015500E-03 |
| Grade 3-vs-Grade 4 |
1.725550E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.321800E-03 |
| Normal-vs-ccB subtype |
3.216600E-04 |
| ccA subtype-vs-ccB subtype |
8.539800E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.838310E-04 |
| Normal-vs-N1 |
8.18370000000845E-05 |
| N0-vs-N1 |
9.173700E-02 |
|
|
